An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909 · see citing works

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884 · see citing works

Tick-borne encephalitis

Грицун, Т. С., Lashkevich, V. A., & Gould, E. A. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00206-1 · Cited by 560 · see citing works

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Pardi, N., Hogan, M. J., Naradikian, M. S., Parkhouse, K., Cain, D. W., Jones, L., Moody, M. A., Verkerke, H. P., Myles, A., Willis, E., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171450 · Cited by 530 · see citing works

West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

Davis, B. S., Chang, G. J., Cropp, B. C., Roehrig, J. T., Martin, D. A., Mitchell, C. J., Bowen, R. A., & Bunning, M. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4040-4047.2001 · Cited by 447 · see citing works

Rapid development of a DNA vaccine for Zika virus

Dowd, K. A., Ko, S., Morabito, K. M., Yang, E. S., Pelc, R. S., DeMaso, C. R., Castilho, L. R., Abbink, P., Boyd, M. B., Nityanandam, R., et al. (2016) · Science · doi:10.1126/science.aai9137 · Cited by 396 · see citing works

Structural Basis of Zika Virus-Specific Antibody Protection

Zhao, H., Fernández, E., Dowd, K. A., Speer, S. D., Platt, D. J., Gorman, M. J., Govero, J., Nelson, C. A., Pierson, T. C., Diamond, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.020 · Cited by 377 · see citing works

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Gaudinski, M. R., Houser, K. V., Morabito, K. M., Hu, Z., Yamshchikov, G. V., Rothwell, R. S., Berkowitz, N. M., Mendoza, F. H., Saunders, J. G., Novik, L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)33105-7 · Cited by 302 · see citing works

Genetic characterization of tick-borne flaviviruses: New insights into evolution, pathogenetic determinants and taxonomy

Grard, G., Moureau, G., Charrel, R. N., Lemasson, J., Gonzalez, J., Gallian, P., Грицун, Т. С., Holmes, E. C., Gould, E. A., & de Lamballerie, X. N. (2006) · Virology · doi:10.1016/j.virol.2006.09.015 · Cited by 276 · see citing works

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease

Richner, J. M., Jagger, B. W., Shan, C., Fontes, C. R., Dowd, K. A., Cao, B., Himansu, S., Caine, E. A., Nunes, B. T. D., Medeiros, D. B. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.040 · Cited by 267 · see citing works

Field effectiveness of vaccination against tick-borne encephalitis

Heinz, F. X., Holzmann, H., Essl, A., & Kundi, M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.024 · Cited by 263 · see citing works

Blocking Monoclonal Antibodies Specific for Mouse IFN- α / β Receptor Subunit 1 (IFNAR-1) from Mice Immunized by In Vivo Hydrodynamic Transfection

Sheehan, K. C. F., Lai, K. S., Dunn, G. P., Bruce, A. T., Diamond, M. S., Heutel, J. D., Dungo-Arthur, C., Carrero, J. A., White, J. M., Hertzog, P. J., et al. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.804 · Cited by 260 · see citing works

Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants

Purtha, W. E., Tedder, T. F., Johnson, S., Bhattacharya, D., & Diamond, M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110740 · Cited by 252 · see citing works

Update on Powassan Virus: Emergence of a North American Tick-Borne Flavivirus

Ebel, G. D. (2009) · Annual Review of Entomology · doi:10.1146/annurev-ento-112408-085446 · Cited by 240 · see citing works

A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection

Pierson, T. C., Sánchez, M. D., Puffer, B. A., Ahmed, A. A., Geiss, B. J., Valentine, L. E., Altamura, L. A., Diamond, M., & Doms, R. W. (2005) · Virology · doi:10.1016/j.virol.2005.10.030 · Cited by 224 · see citing works

Modified mRNA Vaccines Protect against Zika Virus Infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.016 · Cited by 221 · see citing works

Powassan virus: isolation of virus from a fatal case of encephalitis.

McLean, D. M., & Donohue, W. L. (1959) · PubMed · Cited by 219 · see citing works

Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America

Hermance, M. E., & Thangamani, S. (2017) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2017.2110 · Cited by 214 · see citing works

Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form

Allison, S. L., Stadler, K., Mandl, C. W., Kunz, C., & Heinz, F. X. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5816-5820.1995 · Cited by 212 · see citing works

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

Monath, T. P. C., Nichols, R., Archambault, W. T., Moore, L., Marchesani, R., Tian, J., Shope, R. E., Thomas, N., Schrader, R., Furby, D., et al. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.66.533 · Cited by 179 · see citing works

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

Ishikawa, T., Yamanaka, A., & Konishi, E. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.040 · Cited by 175 · see citing works

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection

Collins, M. H., McGowan, E., Jadi, R., Young, E., Lopez, C. A., Baric, R. S., Lazear, H. M., & de Silva, A. M. (2017) · Emerging infectious diseases · doi:10.3201/eid2305.161630 · Cited by 174 · see citing works

Mice immunized with a subviral particle containing the japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

Konishi, E., Pincus, S., Paoletti, E., Shope, R. E., Burrage, T. G., & Mason, P. W. (1992) · Virology · doi:10.1016/0042-6822(92)90526-u · Cited by 170 · see citing works

Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine

Mason, R. A., Tauraso, N. M., Spertzel, R. O., & Ginn, R. K. (1973) · Applied Microbiology · doi:10.1128/am.25.4.539-544.1973 · Cited by 165 · see citing works

Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas

Montoya, M., Collins, M. H., Dejnirattisai, W., Katzelnick, L. C., Puerta-Guardo, H. N., Jadi, R., Schildhauer, S., Supasa, P., Vasanawathana, S., Malasit, P., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy164 · Cited by 141 · see citing works

Complete Genomic Sequence of Powassan Virus: Evaluation of Genetic Elements in Tick-Borne versus Mosquito-Borne Flaviviruses

Mandl, C. W., Holzmann, H., Künz, C., & Heinz, F. X. (1993) · Virology · doi:10.1006/viro.1993.1247 · Cited by 128 · see citing works

Propagation, Quantification, Detection, and Storage of West Nile Virus

Brien, J. D., Lazear, H. M., & Diamond, M. (2013) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc15d03s31 · Cited by 120 · see citing works

Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine

Konishi, E., & Fujii, A. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00446-7 · Cited by 118 · see citing works

Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation

Ansarah-Sobrinho, C., Nelson, S., Jost, C. A., Whitehead, S. S., & Pierson, T. C. (2008) · Virology · doi:10.1016/j.virol.2008.08.021 · Cited by 113 · see citing works

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host

Kuhn, R. J., Dowd, K. A., Post, C. B., & Pierson, T. C. (2015) · Virology · doi:10.1016/j.virol.2015.03.025 · Cited by 111 · see citing works

Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis

Heinz, F. X., Allison, S. L., Stiasny, K., Schalich, J., Holzmann, H., Mandl, C. W., & Künz, C. (1995) · Vaccine · doi:10.1016/0264-410x(95)00133-l · Cited by 107 · see citing works

Zika virus–related neurotropic flaviviruses infect human placental explants and cause fetal demise in mice

Platt, D. J., Smith, A. M., Arora, N., Diamond, M. S., Coyne, C. B., & Miner, J. J. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao7090 · Cited by 107 · see citing works

Tick Saliva Enhances Powassan Virus Transmission to the Host, Influencing Its Dissemination and the Course of Disease

Hermance, M. E., & Thangamani, S. (2015) · Journal of Virology · doi:10.1128/jvi.01056-15 · Cited by 104 · see citing works

Phylogeny of North American Powassan virus

Ebel, G. D., Spielman, A., & Telford, S. R. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-7-1657 · Cited by 100 · see citing works

Type I Interferon Protects Mice from Fatal Neurotropic Infection with Langat Virus by Systemic and Local Antiviral Responses

Weber, E., Finsterbusch, K., Lindquist, R., Nair, S., Lienenklaus, S., Gekara, N. O., Janik, D., Weiß, S., Kalinke, U., Överby, A. K., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01215-14 · Cited by 91 · see citing works

Variation of the Specificity of the Human Antibody Responses after Tick-Borne Encephalitis Virus Infection and Vaccination

Jarmer, J., Zlatkovic, J., Tsouchnikas, G., Vratskikh, O., Strauß, J., Aberle, J. H., Chmelı́k, V., Kundi, M., Stiasny, K., & Heinz, F. X. (2014) · Journal of Virology · doi:10.1128/jvi.02086-14 · Cited by 91 · see citing works

The Prevalence of Zoonotic Tick-Borne Pathogens in Ixodes Scapularis Collected in the Hudson Valley, New York State

Aliota, M. T., Dupuis, A. P., Wilczek, M. P., Peters, R. J., Ostfeld, R. S., & Kramer, L. D. (2014) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2013.1475 · Cited by 87 · see citing works

RANDOMIZED, DOUBLE-BLIND, PHASE III, PIVOTAL FIELD TRIAL OF THE COMPARATIVE IMMUNOGENICITY, SAFETY, AND TOLERABILITY OF TWO YELLOW FEVER 17D VACCINES (ARILVAX™ AND YF-VAX®) IN HEALTHY INFANTS AND CHILDREN IN PERU

BELMUSTO-WORN, V. E., Sánchez, J. L., McCARTHY, K., Nichols, R., Bautista, C. T., Magill, A. J., PASTOR-CAUNA, G., ECHEVARRIA, C., Laguna-Torres, V. A., Samame-Talledo, B. K., et al. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.72.189 · Cited by 86 · see citing works

Prevalence and Genetic Characterization of Powassan Virus Strains Infecting Ixodes scapularis in Connecticut

Anderson, J. F., & Armstrong, P. M. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0294 · Cited by 82 · see citing works

Infectious cDNA Clones of Langat Tick-Borne Flavivirus That Differ from Their Parent in Peripheral Neurovirulence

Campbell, M. S., & Pletnev, A. G. (2000) · Virology · doi:10.1006/viro.2000.0220 · Cited by 79 · see citing works

A Focus of Deer Tick Virus Transmission in the Northcentral United States

Ebel, G. D., Foppa, I., Spielman, A., & Telford, S. R. (1999) · Emerging infectious diseases · doi:10.3201/eid0504.990423 · Cited by 78 · see citing works

Powassan Virus Disease in the United States, 2006–2016

Krow‐Lucal, E., Lindsey, N. P., Fischer, M., & Hills, S. L. (2018) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2017.2239 · Cited by 78 · see citing works

A VSV-based Zika virus vaccine protects mice from lethal challenge

Emanuel, J., Callison, J. A., Dowd, K. A., Pierson, T. C., Feldmann, H., & Marzi, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29401-x · Cited by 77 · see citing works

An Animal Model for the Tickborne Flavivirus—Omsk Hemorrhagic Fever Virus

Holbrook, M. R., Aronson, J. F., Campbell, G. A., Jones, S. J. M., Feldmann, H., & Barrett, A. D. T. (2004) · The Journal of Infectious Diseases · doi:10.1086/426397 · Cited by 68 · see citing works

Stable Prevalence of Powassan Virus in Ixodes scapularis in a Northern Wisconsin Focus

Brackney, D. E., Nofchissey, R. A., Fitzpatrick, K. A., Brown, I. K., & Ebel, G. D. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.79.971 · Cited by 67 · see citing works

Isolation of a Virus Closely Related to Powassan Virus from Dermacentor andersoni Collected along North Cache la Poudre River, Colo

Thomas, L. A., Kennedy, R. C., & Eklund, C. M. (1960) · Experimental Biology and Medicine · doi:10.3181/00379727-104-25836 · Cited by 67 · see citing works

Characterization of Powassan viruses from Far Eastern Russia

Leonova, G. N., Геннадьевич, К. И., Ternovoi, V. A., Романова, Е. В., Протопопова, Е. В., Чаусов, Е. В., Pavlenko, E. V., Ryabchikova, E. I., Беликов, С. И., & Loktev, V. B. (2009) · Archives of Virology · doi:10.1007/s00705-009-0376-y · Cited by 57 · see citing works

Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev

Mandl, C. W., Iacono-Connors, L. C., Wallner, G., Holzmann, H., Künz, C., & Heinz, F. X. (1991) · Virology · doi:10.1016/0042-6822(91)90567-u · Cited by 55 · see citing works

Spinal Cord Ventral Horns and Lymphoid Organ Involvement in Powassan Virus Infection in a Mouse Model

Santos, R. I., Hermance, M. E., Gelman, B. B., & Thangamani, S. (2016) · Viruses · doi:10.3390/v8080220 · Cited by 54 · see citing works

Modeling Powassan virus infection in Peromyscus leucopus, a natural host

Mlera, L., Meade-White, K. D., Saturday, G. A., Scott, D. P., & Bloom, M. E. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005346 · Cited by 54 · see citing works

Impact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein E

Kiermayr, S., Stiasny, K., & Heinz, F. X. (2009) · Journal of Virology · doi:10.1128/jvi.00660-09 · Cited by 46 · see citing works

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

McAuley, A. J., Sawatsky, B., Ksiazek, T. G., Torres, M., Korva, M., Lotrič‐Furlan, S., Avšič‐Županc, T., von Messling, V., Holbrook, M. R., Freiberg, A. N., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0009-5 · Cited by 46 · see citing works

Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin

Chernokhaeva, L. L., Rogova, Y. V., Vorovitch, M. F., Romanova, L. I., Kozlovskaya, L. I., Maikova, G. B., Сергеевич, Х. И., & Karganova, G. G. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.041 · Cited by 39 · see citing works

Pseudo-infectious Reporter Virus Particles for Measuring Antibody-Mediated Neutralization and Enhancement of Dengue Virus Infection

Mukherjee, S., Pierson, T. C., & Dowd, K. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0348-1_6 · Cited by 34 · see citing works

Powassan/Deer Tick Virus and Borrelia Burgdorferi Infection in Wisconsin Tick Populations

Knox, K. K., Thomm, A. M., Harrington, Y. A., Ketter, E., Patitucci, J. M., & Carrigan, D. R. (2017) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2016.2082 · Cited by 30 · see citing works

Fatal Neurological Respiratory Insufficiency Is Common Among Viral Encephalitides

Wang, H., Siddharthan, V., Kesler, K. K., Hall, J., Motter, N. E., Julander, J., & Morrey, J. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit186 · Cited by 18 · see citing works

Characteristics of far eastern strains of tick-borne encephalitis virus

Leonova, G. N., Беликов, С. И., & Kondratov, I. G. (2017) · Archives of Virology · doi:10.1007/s00705-017-3309-1 · Cited by 11 · see citing works

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works

The continued threat of emerging flaviviruses

Pierson, T. C., & Diamond, M. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0714-0 · Cited by 1,075 · see citing works

Advances in mRNA Vaccines for Infectious Diseases

Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00594 · Cited by 680 · see citing works

Emerging Tick-Borne Diseases

Madison‐Antenucci, S., Kramer, L. D., Gebhardt, L. L., & Kauffman, E. B. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00083-18 · Cited by 594 · see citing works

Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery

Wang, X., Liu, S., Sun, Y., Yu, X., Lee, S. M., Cheng, Q., Wei, T., Gong, J., Robinson, J. J., Zhang, D., et al. (2022) · Nature Protocols · doi:10.1038/s41596-022-00755-x · Cited by 567 · see citing works

Recent advances in mRNA vaccine technology

Pardi, N., Hogan, M. J., & Weissman, D. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.008 · Cited by 512 · see citing works

Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects

Kiaie, S. H., Zolbanin, N. M., Ahmadi, A., Bagherifar, R., Valizadeh, H., Kashanchi, F., & Jafari, R. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01478-7 · Cited by 261 · see citing works

Vaccines for COVID-19: The current state of play

Koirala, A., Joo, Y. J., Khatami, A., Chiu, C., & Britton, P. N. (2020) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2020.06.010 · Cited by 235 · see citing works

Recent Advances in Lipid Nanoparticles for Delivery of mRNA

Yang, L., Gong, L., Wang, P., Zhao, X., Zhao, F. H., Zhang, Z., Li, Y., & Huang, W. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122682 · Cited by 178 · see citing works

Recent Advancement in mRNA Vaccine Development and Applications

Fayez, N. A., Nassar, M. S., Alshehri, A. A., Alnefaie, M. K., Almughem, F. A., Alshehri, B. Y., Alawad, A. O., & Tawfik, E. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071972 · Cited by 177 · see citing works

A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses

Wollner, C. J., Richner, M., Hassert, M., Pinto, A. K., Brien, J. D., & Richner, J. M. (2021) · Journal of Virology · doi:10.1128/jvi.02482-20 · Cited by 119 · see citing works

Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid‐Nanoparticle Components for Therapeutic and Vaccine Applications

Lam, K., Leung, A., Martin, A., Wood, M., Schreiner, P., Palmer, L., Daly, O. M., Zhao, W., McClintock, K., & Heyes, J. A. (2023) · Advanced Materials · doi:10.1002/adma.202209624 · Cited by 117 · see citing works

Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity

Zhu, Y., Ma, J., Shen, R., Lin, J., Li, S., Lu, X., Stelzel, J. L., Kong, J., Cheng, L., Vuong, I., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01131-0 · Cited by 109 · see citing works

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity

Wu, L., Li, X., Qian, X., Wang, S., Liu, J., & Yan, J. (2024) · Vaccines · doi:10.3390/vaccines12020186 · Cited by 125 · see citing works

Messenger RNA-Based Vaccines Against Infectious Diseases

Alameh, M.-G., Weissman, D., & Pardi, N. (2020) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2020_202 · Cited by 96 · see citing works

Development of mRNA Lipid Nanoparticles: Targeting and Therapeutic Aspects

Liu, Y., Huang, Y., He, G., Guo, C., Dong, J., & Wu, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810166 · Cited by 98 · see citing works

Current Advances in Zika Vaccine Development

Wang, Y., Ling, L., Zhang, Z., & Marín-López, A. (2022) · Vaccines · doi:10.3390/vaccines10111816 · Cited by 91 · see citing works

mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases

Le, T., Sun, C., Chang, J., Zhang, G., & Yin, X. (2022) · Viruses · doi:10.3390/v14020401 · Cited by 93 · see citing works

Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise

Kubinski, M., Beicht, J., Gerlach, T. H., Volz, A., Sutter, G., & Rimmelzwaan, G. F. (2020) · Vaccines · doi:10.3390/vaccines8030451 · Cited by 85 · see citing works

Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications

Lopes, C., Cristóvão, J. S., Silvério, V., Lino, P. R., & Fonte, P. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2135502 · Cited by 85 · see citing works

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics

Semple, S. C., Leone, R. D., Barbosa, C., Tam, Y. K., & Lin, P. J. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020398 · Cited by 80 · see citing works

RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?

Sandbrink, J. B., & Shattock, R. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.608460 · Cited by 79 · see citing works

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats

Echaide, M., Chocarro, L., Bocanegra, A., Blanco, E., Kochan, G. T., & Escors, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065944 · Cited by 82 · see citing works

mRNA vaccines: Past, present, future

Karam, M., & Daoud, G. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.05.003 · Cited by 74 · see citing works

Induced Transient Immune Tolerance in Ticks and Vertebrate Host: A Keystone of Tick-Borne Diseases?

Boulanger, N., & Wikel, S. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.625993 · Cited by 70 · see citing works

Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axis

Desai, P., Jáňová, H., White, J. P., Reynoso, G. V., Hickman, H. D., Baldridge, M. T., Urban, J. F., Stappenbeck, T. S., Thackray, L. B., & Diamond, M. (2021) · Cell · doi:10.1016/j.cell.2021.01.051 · Cited by 66 · see citing works

Development and applications of mRNA treatment based on lipid nanoparticles

Wang, Z., Ma, W., Fu, X., Qi, Y., Zhao, Y., & Zhang, S. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108130 · Cited by 57 · see citing works

mRNA lipid nanoparticle formulation, characterization and evaluation

Ma, Y., VanKeulen-Miller, R., & Fenton, O. S. (2025) · Nature Protocols · doi:10.1038/s41596-024-01134-4 · Cited by 54 · see citing works

Lipid nanoparticle-based mRNA candidates elicit potent T cell responses

Zeng, Y., Escalona-Rayo, O., Knol, R. A., Kros, A., & Slütter, B. (2022) · Biomaterials Science · doi:10.1039/d2bm01581a · Cited by 54 · see citing works

Transmission Cycle of Tick-Borne Infections and Co-Infections, Animal Models and Diseases

Rocha, S. C., Velásquez, C. V., Aquib, A., Al-Nazal, A., & Parveen, N. (2022) · Pathogens · doi:10.3390/pathogens11111309 · Cited by 50 · see citing works

Acquired tick resistance: The trail is hot

Narasimhan, S., Kurokawa, C., DeBlasio, M., Matias, J., Sajid, A., Pal, U., Lynn, G. E., & Fikrig, E. (2020) · Parasite Immunology · doi:10.1111/pim.12808 · Cited by 50 · see citing works

Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application

Cordeiro, A. S., Patil‐Sen, Y., Shivkumar, M., Patel, R., Khedr, A., & Elsawy, M. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122091 · Cited by 50 · see citing works

mRNA vaccines in the prevention and treatment of diseases

Gu, Y., Duan, J., Yang, N., Yang, Y., & Zhao, X. (2022) · MedComm · doi:10.1002/mco2.167 · Cited by 51 · see citing works

Tick-Borne Encephalitis—Review of the Current Status

Kwaśnik, M., Rola, J., & Rożek, W. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206603 · Cited by 48 · see citing works

Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design

Cai, X., Li, J. J., Liu, T., Brian, O., & Li, J. (2021) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab027 · Cited by 47 · see citing works

Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality

Maciejewski, S. M., Ruckwardt, T. J., Morabito, K. M., Foreman, B. M., Burgomaster, K. E., Gordon, D. N., Pelc, R. S., DeMaso, C. R., Ko, S., Fisher, B. E., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw9066 · Cited by 45 · see citing works

mRNA Vaccines against Flaviviruses

Wollner, C. J., & Richner, J. M. (2021) · Vaccines · doi:10.3390/vaccines9020148 · Cited by 44 · see citing works

Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production

Harioudh, M. K., Pérez, J., Chong, Z., Nair, S., So, L., McCormick, K. D., Ghosh, A., Shao, L., Srivastava, R., Soveg, F. W., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.002 · Cited by 44 · see citing works

Powassan Virus Encephalitis

Piantadosi, A. L., & Solomon, I. H. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.03.003 · Cited by 40 · see citing works

Universal Tick Vaccines: Candidates and Remaining Challenges

Parizi, L. F., Githaka, N., Logullo, C., Zhou, J., Onuma, M., Termignoni, C., & Vaz, I. D. S. (2023) · Animals · doi:10.3390/ani13122031 · Cited by 37 · see citing works

RNase H-based analysis of synthetic mRNA 5′ cap incorporation

Chan, S., Whipple, J. M., Dai, N., Kelley, T. M., Withers, K., Tzertzinis, G., Junior, I. R. C., & Robb, G. B. (2022) · RNA · doi:10.1261/rna.079173.122 · Cited by 33 · see citing works

A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice

He, L., Sun, W., Yang, L., Liu, W., & Li, J. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.07.003 · Cited by 32 · see citing works

mRNA-Based Vaccines and Mode of Action

Gergen, J., & Petsch, B. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_230 · Cited by 32 · see citing works

Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy

Bouazzaoui, A., & Abdellatif, A. A. H. (2024) · Vaccine X · doi:10.1016/j.jvacx.2024.100500 · Cited by 29 · see citing works

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses

VanBlargan, L. A., Errico, J. M., Kafai, N. M., Burgomaster, K. E., Jethva, P. N., Broeckel, R. M., Meade-White, K. D., Nelson, C. A., Himansu, S., Wang, D., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210174 · Cited by 28 · see citing works

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

Choi, H., Kudchodkar, S. B., Ho, M., Reuschel, E. L., Reynolds, E. S., Xu, Z., Bordoloi, D., Ugen, K. E., Tebas, P., Kim, J., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008788 · Cited by 25 · see citing works

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family

Wong, S. H., Jassey, A., Wang, J. Y., Wang, W.-C., Liu, C., & Lin, L. (2019) · Vaccines · doi:10.3390/vaccines7040123 · Cited by 24 · see citing works

Powassan Viruses Spread Cell to Cell during Direct Isolation from Ixodes Ticks and Persistently Infect Human Brain Endothelial Cells and Pericytes

Conde, J. N., Sánchez-Vicente, S., Saladino, N., Gorbunova, E. E., Schutt, W. R., Mladinich, M. C., Himmler, G. E., Benach, J. L., Kim, H. K., & Mackow, E. R. (2021) · Journal of Virology · doi:10.1128/jvi.01682-21 · Cited by 23 · see citing works

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice

Malonis, R. J., Georgiev, G. I., Haslwanter, D., VanBlargan, L. A., Fallon, G., Vergnolle, O., Cahill, S. M., Harris, R., Cowburn, D., Chandran, K., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010573 · Cited by 24 · see citing works

A comprehensive review of tick-borne disease epidemiology, clinical manifestations, pathogenesis, and prevention

Gong, L., Diao, L., Lv, T., Liu, Y., Liu, J., Zhang, W., Xie, X., & Cao, Y. (2025) · Animals and zoonoses. · doi:10.1016/j.azn.2025.05.004 · Cited by 23 · see citing works

Coxsackievirus A6 Infection Causes Neurogenic Pathogenesis in a Neonatal Murine Model

Sun, Q., Li, J., Wang, R., Sun, T., Zong, Y., Wang, C., Liu, Y., Li, X., Song, Y., & Zhang, Y. (2023) · Viruses · doi:10.3390/v15020511 · Cited by 23 · see citing works

Development of a small animal model for deer tick virus pathogenesis mimicking human clinical outcome

Hermance, M. E., Hart, C. E., Esterly, A. T., Reynolds, E. S., Bhaskar, J. R., & Thangamani, S. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008359 · Cited by 23 · see citing works

Age-dependent Powassan virus lethality is linked to glial cell activation and divergent neuroinflammatory cytokine responses in a murine model

Mladinich, M. C., Himmler, G. E., Conde, J. N., Gorbunova, E. E., Schutt, W. R., Sarkar, S., Tsirka, S.-A. E., Kim, H. K., & Mackow, E. R. (2024) · Journal of Virology · doi:10.1128/jvi.00560-24 · Cited by 22 · see citing works

Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination

Stone, E. T., Hassert, M., Geerling, E., Wagner, C., Brien, J. D., Ebel, G. D., Hirsch, A. J., German, C. N., Smith, J. L., & Pinto, A. K. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110388 · Cited by 22 · see citing works

Advances in the study of LNPs for mRNA delivery and clinical applications

Wang, B., Shen, B., Xiang, W., & Shen, H. (2024) · Virus Genes · doi:10.1007/s11262-024-02102-6 · Cited by 21 · see citing works

SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants

Mahalingam, G., Rachamalla, H. K., Arjunan, P., Karuppusamy, K. V., Periyasami, Y., Mohan, A., Subramaniyam, K., Salma, M., Rajendran, V., Moorthy, M., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.02.028 · Cited by 21 · see citing works

Pathological Characteristics of Echovirus 30 Infection in a Mouse Model

Li, J., Zhang, G., Sun, Q., Zhang, K., Lu, H., Xiao, J., Han, Z., Zhao, H., Xu, W., Zhang, Y., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00129-22 · Cited by 19 · see citing works

T Cells in Tick-Borne Flavivirus Encephalitis: A Review of Current Paradigms in Protection and Disease Pathology

Stone, E. T., & Pinto, A. K. (2023) · Viruses · doi:10.3390/v15040958 · Cited by 18 · see citing works

Immunoinformatics and computational approaches driven designing a novel vaccine candidate against Powassan virus

Nguyen, T. L., & Kim, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-56554-9 · Cited by 18 · see citing works

Of Murines and Humans: Modeling Persistent Powassan Disease in C57BL/6 Mice

Scroggs, S. L. P., Offerdahl, D. K., Stewart, P. E., Shaia, C., Griffin, A. J., & Bloom, M. E. (2023) · mBio · doi:10.1128/mbio.03606-22 · Cited by 17 · see citing works

Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model

Cheung, A. M., Yip, E. Z., Ashbrook, A. W., Goonawardane, N., Quirk, C., Rice, C. M., MacDonald, M. R., & Hoffmann, H.-H. (2023) · Vaccines · doi:10.3390/vaccines11030612 · Cited by 17 · see citing works

Designing novel multiepitope mRNA vaccine targeting Hendra virus (HeV): An integrative approach utilizing immunoinformatics, reverse vaccinology, and molecular dynamics simulation

Mahdeen, A. A., Hossain, I., Masum, M. H. U., Islam, M. S., & Rabbi, T. M. F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312239 · Cited by 17 · see citing works

Powassan virus: A tick borne flavivirus infecting humans

Xu, Y., Gao, G. F., & Liu, W. J. (2022) · Biosafety and Health · doi:10.1016/j.bsheal.2021.12.007 · Cited by 16 · see citing works

Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective

Cueto, E. G., de la Fuente, J., & López‐Camacho, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1384442 · Cited by 16 · see citing works

The mRNA vaccine platform for veterinary species

Fazel, F., Doost, J. S., Raj, S., Boodhoo, N., Karimi, K., & Sharif, S. (2024) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2024.110803 · Cited by 18 · see citing works

A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model

Cimica, V., Saleem, S., Matuczinski, E., Adams-Fish, D., McMahon, C., Rashid, S., & Stedman, T. T. (2021) · Pathogens · doi:10.3390/pathogens10060680 · Cited by 14 · see citing works

Current status and future prospects of multi-antigen tick vaccine

Parthasarathi, B. C., Kumar, B., & Ghosh, S. (2021) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.321739 · Cited by 14 · see citing works

The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize

Janowski, M., & Andrzejewska, A. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.07.003 · Cited by 11 · see citing works

Pathogenicity and virulence of Powassan virus

Kaur, M., Adam, M., & Mladinich, M. C. (2025) · Virulence · doi:10.1080/21505594.2025.2523887 · Cited by 12 · see citing works

Effects of glycine 64 substitutions in RNA-dependent RNA polymerase on ribavirin sensitivity and pathogenicity of coxsackievirus A6

Wang, R., Sun, Q., Xiao, J., Wang, C., Li, X., Li, J., Song, Y., Lu, H., Liu, Y., Zhu, S., et al. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199268 · Cited by 10 · see citing works

Genetically engineered bacterial‐like particles induced specific cellular and humoral immunity as effective tick‐borne encephalitis virus vaccine

Zhang, M., Jin, H., Li, Y., Jiao, C., Huang, P., Bai, Y., Gong, Z., Zhang, H., Liu, S., & Wang, H. (2023) · Aggregate · doi:10.1002/agt2.305 · Cited by 10 · see citing works

Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residue

Kumari, M., Su, S.-C., Lin, H.-T., Ko, S.-H., Lu, Y.-F., Chen, K.-C., Wy, C., Wu, M.-J., & Wu, H. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127216 · Cited by 9 · see citing works

Generation of Multiple Arbovirus-like Particles Using a Rapid Recombinant Vaccinia Virus Expression Platform

Wang, Y., Griffiths, A., Brackney, D. E., & Verardi, P. H. (2022) · Pathogens · doi:10.3390/pathogens11121505 · Cited by 8 · see citing works

Primary infection with Zika virus provides one-way heterologous protection against Spondweni virus infection in rhesus macaques

Jaeger, A. S., Crooks, C. M., Weiler, A. M., Bliss, M. I., Rybarczyk, S. L., Richardson, A., Einwalter, M. A., Peterson, E. J., Capuano, S., Barkhymer, A. J., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg3444 · Cited by 7 · see citing works

The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccine

Crawford, M. W., Abdelwahab, W., Siram, K., Parkins, C. J., Harrison, H. F., Stone, E. T., Osman, S. R., Schweitzer, D., Burkhart, D. J., Pinto, A. K., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01215-9 · Cited by 7 · see citing works

Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019

Lutz, H., Popowski, K. D., Dinh, P., & Cheng, K. (2020) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000063 · Cited by 7 · see citing works

A mRNA-LNP vaccine against Dengue Virus elicits robust, serotype-specific immunity

Wollner, C. J., Richner, M., Hassert, M. A., Pinto, A. K., Brien, J. D., & Richner, J. M. (2021) · doi:10.1101/2021.01.05.425517 · Cited by 6 · see citing works

Duck IL-7 as a novel adjuvant improves the humoral immune response to an inactivated duck tembusu virus vaccine

Huang, J., Yu, T., Long, Z., Wang, M., Liu, M., Zhu, D., Chen, S., Zhao, X., Yang, Q., Wu, Y., et al. (2023) · Veterinary Microbiology · doi:10.1016/j.vetmic.2023.109665 · Cited by 6 · see citing works

Emerging Trends on Nanovaccine Administration and Functionalization Strategies for Immunization

Dewangan, H. K., Shah, K., Sharma, R. K., Sharma, S., Kumar, A., Khan, M. I., Alghamdi, A. A., & Abbas, M. A. E. (2024) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416524500066 · Cited by 5 · see citing works

Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review

Akamine, C. M., & Sahly, H. M. E. (2021) · Translational research · doi:10.1016/j.trsl.2021.12.007 · Cited by 5 · see citing works

Tick-Borne Viruses of North America

Relich, R. F., & Grabowski, J. M. (2020) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2020.05.001 · Cited by 4 · see citing works

Identification of personalized neoantigen-based vaccines and immune subtype characteristic analysis of glioblastoma based on abnormal alternative splicing.

Deng, Z., Zhan, P., Yang, K., Liu, L., Liu, J., & Gao, W. (2022) · PubMed Central · Cited by 4 · see citing works

mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases

Tan, B. E. K., Tham, S. K., & Poh, C. L. (2025) · Viruses · doi:10.3390/v17070960 · Cited by 4 · see citing works

Coming of age: mRNA vaccines for orthoflaviviruses

Akther, F., Pardi, N., & Martinez, D. R. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.10.005 · Cited by 3 · see citing works

A Fatal Case of Powassan Virus Encephalitis

Carrasco, M., & Horiszny, J. (2024) · Journal of Brown Hospital Medicine · doi:10.56305/001c.117405 · Cited by 3 · see citing works

Orthoflavivirus Vaccine Platforms: Current Strategies and Challenges

Unali, G., & Douam, F. (2025) · Vaccines · doi:10.3390/vaccines13101015 · Cited by 3 · see citing works

A Critical Assessment of COVID-19 Genomic Vaccines

Sabbah, D. A., Hajjo, R., & Sunoqrot, S. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230825094341 · Cited by 3 · see citing works

History, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

Tripathi, V., Mishra, A., Nair, N., Pathak, Y., & Majeed, J. (2021) · Coronaviruses · doi:10.2174/2666796702666210805101958 · Cited by 3 · see citing works

Safety and immunogenicity of inactivated Zika virus vaccine by gamma irradiation

Sintara, P., Suphaprueksapong, P., Jetawattana, S., Wiriyarat, W., Akkhawattanangkul, Y., Charngkaew, K., Chomanee, N., Saelee, J., Wongsa, A., Priengprom, T., et al. (2025) · Vaccine X · doi:10.1016/j.jvacx.2025.100706 · Cited by 2 · see citing works

Nanotechnology in Prophylaxis of Viral Livestock Diseases

Kumar, R., Chowdhury, A., Rose, M. K., Sindhu, S., Syed, S. M., & Ghosh, M. (2024) · Livestock diseases and management · doi:10.1007/978-981-16-1610-5_14 · Cited by 2 · see citing works

Innate Immune Response to Powassan Virus Infection: Progress Toward Infection Control

Kayesh, M. E. H., Kohara, M., & Tsukiyama–Kohara, K. (2025) · Vaccines · doi:10.3390/vaccines13070754 · Cited by 2 · see citing works

RNA vaccines in infectious diseases: A systematic review

Beirigo, E. D. F., Franco, P. I. R., Neto, J. R. D. C., Guerra, R. O., Farnesi-de-Assunção, T. S., Sousa, I. D. O. F., Obata, M. M. S., Rodrigues, W. F., Machado, J. R., & da Silva, M. V. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106372 · Cited by 3 · see citing works

mRNA Vaccines Against Tick‐borne Diseases

Arora, G., & Fikrig, E. (2024) · doi:10.1002/9783527838394.ch10 · Cited by 2 · see citing works

Interferon-alpha/beta receptor deficiency enhances susceptibility to Powassan virus infection in mice

Elsharkawy, A., Pathak, H., Dim, C., & Kumar, M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1678861 · Cited by 1 · see citing works

Powassan virus

Rosado, A. P., & Pinto, A. K. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.11.012 · Cited by 1 · see citing works

A DNA-guided prokaryotic argonaute enables programmable RNA cleavage for sequencing and quality control of in vitro-transcribed RNAs

Liu, L., Hunt, E. A., Wolf, E. J., Junior, I. R. C., Yigit, E., & Grünberg, S. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102983 · Cited by 1 · see citing works

Characterization of virus neuroinvasion, blood-brain barrier integrity and neuroinflammation following Powassan virus infection in mice

Pathak, H., Elsharkawy, A., Espínola, E. E., Rothan, H., Arora, K., Dim, C. E., Stone, S., Nabi, Z., & Kumar, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1813928 · Cited by 1 · see citing works

Pathogenesis and neurotropism of a contemporary Powassan virus lineage II strain in mice

Courtney, S. J., Gallichotte, E. N., Nilsson, E., Trammell, C. E., Kimball, K. X., Fagre, A. C., Vilander, A. C., Överby, A. K., & Ebel, G. D. (2026) · Journal of Virology · doi:10.1128/jvi.00585-26 · Cited by 1 · see citing works

Nanotechnology in vaccines and personalized medicine

Azevedo, M. S. P., & Patri, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00043-5 · Cited by 1 · see citing works

Ribonucleases for Sequencing and Characterization of RNA by LC–MS

Junior, I. R. C., Wolf, E. J., Yigit, E., & Chan, S. (2023) · RNA technologies · doi:10.1007/978-3-031-36390-0_27 · Cited by 1 · see citing works

A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model

Cimica, V., Saleem, S., Matuczinski, E., Adams-Fish, D., McMahon, C., Rashid, S., & Stedman, T. T. (2021) · Pathogens · doi:10.3390/pathogens10060680 · Cited by 14 · see citing works

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses

VanBlargan, L. A., Errico, J. M., Kafai, N. M., Burgomaster, K. E., Jethva, P. N., Broeckel, R. M., Meade-White, K. D., Nelson, C. A., Himansu, S., Wang, D., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210174 · Cited by 28 · see citing works

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

Choi, H., Kudchodkar, S. B., Ho, M., Reuschel, E. L., Reynolds, E. S., Xu, Z., Bordoloi, D., Ugen, K. E., Tebas, P., Kim, J., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008788 · Cited by 25 · see citing works

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice

Malonis, R. J., Georgiev, G. I., Haslwanter, D., VanBlargan, L. A., Fallon, G., Vergnolle, O., Cahill, S. M., Harris, R., Cowburn, D., Chandran, K., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010573 · Cited by 24 · see citing works

Evaluating adjuvant, formulation, and antigen in the development of a Powassan virus vaccine

Crawford, M. (2026) · OHSU Digital Commons · doi:10.6083/bpxhc44970